Study guide

12.1 Enzymes, Enhancement Media & Lectins

Specialist in Blood Banking, SBB ASCP

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Eligibility Routes & Credential Maintenance 1.3 Study Strategy for SBB

2 Donors & Collection

2.1 Donor Qualification 2.2 Collection Methods & Adverse Reactions 2.3 Special Donations

3 Processing, Storage & Component QC

3.1 Processing, Testing & Labeling 3.2 Storage, Transport & Expiration 3.3 Blood Component Quality Control

4 Red Cell & Modified Components

4.1 Whole Blood & Red Blood Cells 4.2 Leukocyte-Reduced, Washed, Frozen & Rejuvenated RBCs 4.3 Irradiated Components 4.4 Granulocytes

5 Platelets, Plasma & Cellular Products

5.1 Platelets 5.2 Plasma & Cryoprecipitated AHF 5.3 Apheresis Products & Fractionation Products 5.4 Hematopoietic Progenitors

6 Genetics, ABO & Rh

6.1 Blood Group Genetics & Molecular Inheritance 6.2 ABO & Lewis Systems 6.3 Rh System 6.4 MNS, P1PK/Globoside & Ii

7 Other Blood Groups & Role in Transfusion

7.1 Kell, Kidd, Duffy & Lutheran 7.2 Other Systems & High/Low-Prevalence Antigens 7.3 HLA, Platelet-Specific & Granulocyte Antigens 7.4 Immunogenicity & Antigen Prevalence

8 Immunology Foundations

8.1 Immune Response 8.2 Immunoglobulins 8.3 Antigen-Antibody Interactions 8.4 Complement

9 Physiology, Hemostasis & HDFN

9.1 Physiology of Blood 9.2 Hemostasis and Coagulation 9.3 HDFN Pathophysiology & Detection 9.4 HDFN Treatment & Prevention

10 Cytopenias & Transplantation

10.1 Immune & Nonimmune Anemia 10.2 Thrombocytopenia & Neutropenia 10.3 Solid Organ Transplantation Support 10.4 Hematopoietic Progenitor Cell Transplantation

11 Routine Serologic Testing

11.1 Blood Grouping Tests 11.2 Antibody Detection & Crossmatch 11.3 Antibody Identification & Clinical Significance 11.4 Direct Antiglobulin Testing & Reagents

12 Special Serologic Methods

12.1 Enzymes, Enhancement Media & Lectins 12.2 Adsorptions, Elutions & Titrations 12.3 Cell Separations, Neutralization & Thiol Reagents 12.4 Chloroquine Diphosphate & EDTA-Glycine Acid

13 Molecular Platforms & Serologic QA

13.1 Molecular Blood Group Techniques 13.2 ELISA, Immunofluorescence, Solid Phase & Column Agglutination 13.3 Serologic Quality Assurance

14 Indications, Component Therapy & PBM

14.1 Indications for Transfusion 14.2 Component Therapy 14.3 Blood Administration & Patient Blood Management

15 Adverse Effects of Transfusion

15.1 Immunologic Transfusion Reactions 15.2 Nonimmunologic Reactions 15.3 Transfusion-Transmitted Diseases

16 Apheresis & Extracorporeal Circulation

16.1 Therapeutic Apheresis 16.2 Extracorporeal Circulation

17 Quality, Safety, Math & Instrumentation

17.1 Quality Assessment & Troubleshooting 17.2 Laboratory Safety 17.3 Laboratory Mathematics 17.4 Instrumentation

18 Laboratory Administration (SBB Only)

18.1 Financial Management 18.2 Operations & Information Technology 18.3 Personnel, Education & Training 18.4 Quality Management, Risk & Tissue Management

12.1 Enzymes, Enhancement Media & Lectins

Key Takeaways Explain This Topic AI

Ficin and papain enhance detection of Rh, Kidd, Lewis, I, and P1 antibodies but destroy M, N, S, s, Fya, Fyb, Xga, and Ch/Rg antigens.

LISS shortens IAT incubation to about 10-15 minutes by lowering ionic strength around the red cell.

PEG increases sensitivity for weak IgG antibodies but must be read with monospecific anti-IgG AHG, never polyspecific AHG, to avoid complement-driven false positives.

Ulex europaeus (anti-H) confirms Bombay phenotype and distinguishes A2 subgroups; Dolichos biflorus (anti-A1) distinguishes A1 from A2.

Two-stage enzyme technique (pretreat cells, then test) gives stronger, more reproducible reactions than one-stage enzyme testing.

Last updated: July 2026

Why Special Serologic Techniques Matter

Routine ABO/Rh typing, antibody screens, and standard antiglobulin panels solve most transfusion service problems, but a meaningful fraction of workups need a second toolkit : proteolytic enzymes, enhancement media, and plant lectins. These techniques change how an antibody or antigen presents itself in vitro, either by stripping surface molecules off the red cell membrane, altering the ionic environment around the cell, or exploiting a plant protein's unusual sugar specificity. The SBB exam expects you to know not just what each reagent does, but which antigens it destroys , which antibodies it enhances , and when a real-world discrepancy points you toward using it .

Proteolytic Enzymes: Ficin and Papain

Ficin (from fig latex) and papain (from papaya) are the two proteolytic enzymes routinely used in blood bank serology. Both cleave sialoglycoprotein and surface-protein residues from the red cell membrane. Two things happen when this occurs:

Zeta potential drops. Removing negatively charged sialic acid-rich glycoproteins lets red cells approach each other more closely in saline, so IgG antibodies that could not bridge the normal intercellular distance can now cause direct agglutination without an antihuman globulin (AHG) phase.

Some antigens are destroyed. The same cleavage that helps antibody uptake also strips off antigens carried on the sialoglycoproteins that get clipped away.

Enzyme technique: one-stage vs. two-stage

One-stage technique - enzyme, serum, and reagent red cells are all combined and incubated together. It is faster but less standardized and gives weaker, more variable reactions; mainly used as a quick screening adjunct.

Two-stage technique - reagent red cells are pretreated with enzyme, washed free of residual enzyme, and then incubated with test serum. This is the standard method for antibody-identification panels because reaction strength is reproducible and stronger.

What enzymes enhance vs. destroy

  • Effect Antigens/Antibodies
  • Enhanced (stronger reactions) Rh system (D, C, c, E, e), Kidd (Jka, Jkb), Lewis (Lea, Leb), I, P1
  • Destroyed (antigen denatured) M, N, S, s, Fya, Fyb, Xga, Ch/Rg (Chido/Rodgers)
  • Unaffected ABO, Kell (K, k), Kidd, Rh
  • Worked example

A patient's serum reacts 2+ with every enzyme-treated panel cell but is negative in the saline-IAT (indirect antiglobulin test) panel using untreated cells. This pattern - reactive only after enzyme treatment - should immediately make you suspect an antibody to an antigen that enzymes enhance rather than destroy, such as anti-Jka, anti-Jkb, anti-Lea, or an Rh antibody with weak native reactivity. Conversely, if a panel reacts normally with untreated cells but the reactions disappear after enzyme treatment, the antibody is very likely directed at an enzyme-labile antigen: M, N, S, s, Fya, or Fyb. This rule-in/rule-out logic - comparing an enzyme panel against a standard IAT panel - is one of the most heavily tested antibody-identification skills on the SBB exam.

  • Enhancement Media: LISS and PEG
  • Low Ionic Strength Saline (LISS)

LISS lowers the ionic strength of the reaction medium, which reduces the ionic cloud around each red cell (zeta potential) and speeds antibody uptake onto the membrane. Practical effects:

Shortens IAT incubation from the traditional 30-60 minutes down to 10-15 minutes .

Increases antibody uptake, improving detection of weak antibodies.

Caution : excessive incubation time or an improper serum-to-cell ratio with LISS can cause nonspecific IgG uptake, producing false-positive reactions - always follow the manufacturer's exact incubation time.

Polyethylene Glycol (PEG)

PEG is a high-molecular-weight polymer added to the IAT phase that removes free water from the test system, effectively concentrating antibody molecules near the red cell surface and driving more antibody onto the membrane.

Increases sensitivity for weak IgG antibodies (e.g., faint anti-K, anti-Fya, anti-Jkb) that might be missed with saline-IAT alone.

Must be read only with monospecific anti-IgG AHG , never polyspecific AHG - PEG also promotes nonspecific complement (C3d) uptake, and polyspecific AHG (which contains anti-C3d) will produce false-positive reactions with PEG-enhanced cells.

PEG-treated tests should not be over-incubated or over-read, since PEG already increases nonspecific aggregation risk if handled outside protocol.

Lectins: Plant Proteins as Reagent Antisera

Lectins are proteins or glycoproteins extracted from plant seeds that bind specific carbohydrate residues on the red cell membrane, agglutinating cells that carry the matching sugar structure. Because each lectin's sugar specificity happens to match a blood group antigen's terminal sugar, lectins function as inexpensive, highly specific reagent antisera substitutes.

Lectin Source Specificity Primary Use

Ulex europaeus (gorse seed) Anti-H Confirms Bombay (Oh) phenotype (no reaction) vs. A2/A2B subgroups (strong reaction, more H antigen than A1/A1B cells)

Dolichos biflorus Anti-A1 Distinguishes A1 from A2 subgroup - agglutinates A1 cells, does not agglutinate A2 cells

Vicia graminea Anti-N Identifies N antigen, useful in rare antibody workups

Arachis hypogaea (peanut) Anti-T Detects T-activation (polyagglutination) from bacterial/enzymatic exposure of the T-antigen, e.g., in sepsis

  • Salvia sclarea / Glycine soja Anti-Tn Detects Tn-activation, another polyagglutination pattern
  • Worked example

A patient's forward type is group A, but reverse grouping shows unexpected agglutination with reagent A1 cells (the patient's own serum reacting against them). This classic ABO discrepancy suggests the patient may be an A2 subgroup with an anti-A1 . Testing the patient's red cells against Dolichos biflorus (anti-A1 lectin) resolves it: no agglutination confirms A2 (lacking A1 antigen), which is consistent with the anti-A1 finding, since roughly 1-8% of A2 individuals produce anti-A1.